Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents

Published:2012-04-12 Issue:3 Volume:20 Page:262-273
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Jarosz M,Jazowiecka-Rakus J,Cichoń T,Głowala-Kosińska M,Smolarczyk R,Smagur A,Malina S,Sochanik A,Szala S

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt201228.pdf

Reference71 articles.

1. Tabi Z, Man S . Challenges for cancer vaccine development. Adv Drug Deliv Rev 2006; 58: 902–915.

2. Hofmeister V, Vetter C, Schrama D, Bröcker E-B, Becker JC . Tumor stroma-associated antigens for anti-cancer immunotherapy. Cancer Immunol Immunother 2006; 55: 481–494.

3. Azam F, Mehta S, Harris AL . Mechanisms of resistance to antiangiogenesis therapy. Eur J Cancer 2010; 46: 1323–1332.

4. Folkman J . Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182–1186.

5. Ebos JML, Kerbel RS . Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol 2011; 8: 210–221.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?;Frontiers in Immunology;2024-07-16

2. A Novel Cytotoxic Mechanism for Triple-Negative Breast Cancer Cells Induced by the Type II Heat-Labile Enterotoxin LT-IIc through Ganglioside Ligation;Toxins;2024-07-11

3. Exploiting bacteria for cancer immunotherapy;Nature Reviews Clinical Oncology;2024-06-05

4. New Vaccine Therapy for Triple-Negative Breast Cancer;Current Breast Cancer Reports;2024-05-08

5. Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma;Frontiers in Immunology;2022-11-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3